Bijayee Shrestha, MD
Pathology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Diagnostic Pathology Medical Group Inc · 32 clinicians in this group
Looking this up.
Hospitals listed: Sutter Amador Hospital · Sutter Davis Hospital · Sutter Medical Center, Sacramento · Sutter Roseville Medical Center · Sutter Solano Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Shrestha’s office at (916) 446-0424 to ask if they take your plan before you enroll.
California Medical Board record
Licence A120856 · Current
Licensed to practise in California · since 2012 · expires 2027-07-31 · Banaras Hindu University Institute of Medical Sciences.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Amador HospitalJackson, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sutter Davis HospitalDavis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
- Sutter Solano Medical CenterVallejo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.272, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Amador Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 180 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.6 to 1.5) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 233 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 803 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,886 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,831 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.13 (0.63 to 5.63) · 209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.88 to 4.3) · 188 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.99 (0 to 18.96) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.23) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.81 (0 to 1.84) · 1,604 cases | No different | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 138 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.9 · 139 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -27.8 · 230 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.5 · 226 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.1) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (6.9 to 14.9) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.1 to 18.6) · 146 cases | No different | Jan 2022 – Dec 2024 |
What patients said (385 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 81% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Davis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 1 the same, 0 worse of 2 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.07) · 247 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.43 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 151 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.9 · 94 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 857 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,791 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,822 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.22 (0.68 to 5.75) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 41 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.4) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.351 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 169 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13 · 94 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 123 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 34 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.6 to 16.4) · 878 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 240 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 82% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sutter Solano Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.272 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.6 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.36 (106.6 to 218.11) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 65 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 960 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,268 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,327 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.7 (0.38 to 5.03) · 594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 285 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.47 to 3.78) · 581 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.1 (0 to 16.32) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.77 (3.74 to 11.8) · 275 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 114 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.59 (0 to 1.48) · 1,998 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.8 · 171 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.8 · 131 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33 · 162 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 160 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.5) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.8 to 14.4) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 165 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.6 to 18.9) · 322 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.6) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (355 patients answered, 17% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$150,185
Medicare paid this office $150,185 for 712 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Special stained specimen slides to examine tissue, each additional procedure | 66 | $17,155 | $82 |
| Special stained specimen slides to examine tissue, each additional procedure | 140 | $16,827 | $23 |
| Pathology examination of tissue using a microscope, intermediate complexity | 302 | $13,472 | $30 |
| Pathology examination of tissue using a microscope, moderately high complexity | 92 | $11,337 | $67 |
| Special stained specimen slides to examine tissue, initial procedure | 82 | $10,004 | $95 |
See all 32 services
| Special stained specimen slides to examine tissue, each additional procedure | 66 | $17,155 | $82 |
| Special stained specimen slides to examine tissue, each additional procedure | 140 | $16,827 | $23 |
| Pathology examination of tissue using a microscope, intermediate complexity | 302 | $13,472 | $30 |
| Pathology examination of tissue using a microscope, moderately high complexity | 92 | $11,337 | $67 |
| Special stained specimen slides to examine tissue, initial procedure | 82 | $10,004 | $95 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 129 | $9,241 | $67 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 27 | $8,699 | $322 |
| Special stained specimen slides to examine tissue including interpretation and report | 47 | $7,667 | $67 |
| Special stained specimen slides to examine tissue, initial procedure | 166 | $6,081 | $29 |
| Microscopic genetic analysis of tumor, manual | 37 | $5,072 | $108 |
| Pathology examination of tissue using a microscope, intermediate complexity | 80 | $4,952 | $60 |
| Genetic sequencing localization, initial procedure | 30 | $4,803 | $160 |
| Pathology examination of tissue using a microscope, moderately high complexity | 15 | $4,152 | $259 |
| Genetic sequencing localization, each additional procedure | 27 | $3,249 | $120 |
| Bone marrow, smear interpretation | 42 | $2,585 | $60 |
| Microscopic genetic analysis of tumor, manual | 58 | $2,461 | $34 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 42 | $2,183 | $51 |
| Pathology examination of tissue using a microscope, high complexity | 18 | $2,133 | $118 |
| Pathology examination of specimen during surgery, first tissue block | 18 | $2,034 | $51 |
| Preparation of tissue for examination by removing any calcium present | 171 | $1,787 | $10 |
| Genetic sequencing localization, initial procedure | 43 | $1,624 | $35 |
| Bone marrow, smear interpretation | 37 | $1,513 | $40 |
| Cell examination of specimen, selective cellular enhancement technique | 57 | $1,449 | $23 |
| Special stained specimen slides to examine tissue including interpretation and report | 49 | $1,168 | $10 |
| Genetic sequencing localization, each additional procedure | 30 | $1,034 | $28 |
| Preparation of tissue for examination by removing any calcium present | 45 | $797 | $17 |
| Pathology cytologic examination of specimen during surgery, initial site | 13 | $754 | $50 |
| Pathology examination of tissue using a microscope, moderately low complexity | 68 | $712 | $9 |
| Blood smear interpretation by physician with written report | 26 | $532 | $20 |
| Special stained specimen slides to identify organisms including interpretation and report | 13 | $470 | $18 |
| Pathology examination of tissue using a microscope, limited examination | 78 | $287 | $3 |
| Pathology examination of tissue using a microscope | 15 | $83 | $6 |
Who their Medicare patients are
712 Original Medicare patients in 2024. Average age 74 · Under 65 9% · 85 and older 10% · Women 52% · Also on Medicaid 24% · Health risk score 1.69. Above the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Chronic kidney disease 37% · Diabetes 33% · Coronary heart disease 33% · Cancer 32% · Atrial fibrillation 25% · Depression 25% · Heart failure 24% · COPD 21% · Stroke 12% · Dementia 9%.
The office billed $419,181, Medicare allowed $187,977 and paid $150,185; for 3,453 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 712 | 3,453 | 74 | 1.69 | $419,181 | $150,185 |
| 2023 | 793 | 4,613 | 76 | 1.33 | $596,090 | $146,145 |
| 2022 | 644 | 4,175 | 76 | 1.44 | $561,503 | $135,053 |
| 2021 | 719 | 4,122 | 75 | 1.20 | $562,659 | $139,445 |
| 2020 | 661 | 3,690 | 75 | 1.27 | $508,966 | $128,642 |
| 2019 | 928 | 4,775 | 75 | 1.24 | $669,068 | $164,911 |
| 2018 | 798 | 3,815 | 75 | 1.15 | $535,565 | $131,354 |
| 2017 | 843 | 3,624 | 74 | 1.21 | $524,366 | $131,310 |
| 2016 | 765 | 2,847 | 74 | 1.18 | $415,969 | $100,842 |
| 2015 | 760 | 2,894 | 74 | 1.20 | $442,564 | $103,870 |
| 2014 | 793 | 2,908 | 74 | 1.19 | $462,836 | $90,951 |
| 2013 | 735 | 2,416 | 74 | 1.17 | $393,415 | $88,741 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Special stained specimen slides to examine tissue, each additional procedure | 240 | $37,451 | $26 |
| Pathology examination of tissue using a microscope, intermediate complexity | 474 | $29,076 | $34 |
| Special stained specimen slides to examine tissue, initial procedure | 300 | $11,615 | $32 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 141 | $11,444 | $35 |
| Pathology examination of tissue using a microscope, moderately high complexity | 96 | $9,348 | $76 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 107 | $9,048 | $76 |
| Microscopic genetic analysis of tumor, manual | 132 | $8,603 | $38 |
| Genetic sequencing localization, initial procedure | 121 | $5,041 | $39 |
| Bone marrow, smear interpretation | 96 | $4,266 | $44 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 24 | $3,870 | $161 |
| Genetic sequencing localization, each additional procedure | 99 | $3,414 | $31 |
| Special stained specimen slides to examine tissue including interpretation and report | 111 | $2,251 | $11 |
| Pathology examination of tissue using a microscope, high complexity | 11 | $1,612 | $134 |
| Preparation of tissue for examination by removing any calcium present | 125 | $1,476 | $11 |
| Protein measurement, serum | 67 | $1,369 | $16 |
| Pathology examination of specimen during surgery, first tissue block | 13 | $1,036 | $58 |
| Special stained specimen slides to identify organisms including interpretation and report | 21 | $706 | $24 |
| Pathology examination of tissue using a microscope, moderately low complexity | 55 | $643 | $10 |
| Blood smear interpretation by physician with written report | 22 | $484 | $22 |
| Pathology examination of tissue using a microscope, limited examination | 96 | $470 | $4 |
| Cell examination of specimen, selective cellular enhancement technique | 13 | $354 | $25 |
| Immunologic analysis technique on serum (immunofixation) | 16 | $277 | $16 |
| Protein measurement, body fluid | 15 | $245 | $16 |
| Pathology examination of tissue using a microscope | 11 | $74 | $6 |
2022: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 427 | $35,266 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 194 | $30,240 | $26 |
| Special stained specimen slides to examine tissue, initial procedure | 263 | $10,249 | $32 |
| Microscopic genetic analysis of tumor, manual | 129 | $9,451 | $39 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 112 | $9,260 | $77 |
| Pathology examination of tissue using a microscope, moderately high complexity | 82 | $8,235 | $77 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 101 | $8,071 | $36 |
| Bone marrow, smear interpretation | 97 | $4,455 | $45 |
| Genetic sequencing localization, initial procedure | 93 | $3,972 | $41 |
| Genetic sequencing localization, each additional procedure | 82 | $3,096 | $32 |
| Special stained specimen slides to examine tissue including interpretation and report | 108 | $2,345 | $11 |
| Pathology examination of specimen during surgery, first tissue block | 13 | $1,588 | $57 |
| Preparation of tissue for examination by removing any calcium present | 126 | $1,480 | $12 |
| Special stained specimen slides to identify organisms including interpretation and report | 33 | $1,316 | $24 |
| Pathology examination of tissue using a microscope, moderately low complexity | 50 | $634 | $11 |
| Blood smear interpretation by physician with written report | 26 | $606 | $22 |
| Pathology examination of tissue using a microscope, limited examination | 88 | $397 | $4 |
| Examination of archival tissue for genetic analysis | 17 | $303 | $18 |
2021: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 503 | $35,486 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 199 | $30,639 | $27 |
| Special stained specimen slides to examine tissue, initial procedure | 268 | $11,544 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 92 | $10,863 | $79 |
| Microscopic genetic analysis of tumor, manual | 136 | $9,533 | $40 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 106 | $8,846 | $78 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 65 | $5,170 | $36 |
| Genetic sequencing localization, initial procedure | 109 | $4,938 | $41 |
| Bone marrow, smear interpretation | 103 | $4,788 | $46 |
| Genetic sequencing localization, each additional procedure | 94 | $3,804 | $33 |
| Special stained specimen slides to examine tissue including interpretation and report | 123 | $2,666 | $11 |
| Pathology examination of tissue using a microscope, high complexity | 17 | $2,384 | $140 |
| Pathology examination of specimen during surgery, first tissue block | 19 | $1,492 | $60 |
| Preparation of tissue for examination by removing any calcium present | 114 | $1,467 | $12 |
| Special stained specimen slides to identify organisms including interpretation and report | 26 | $1,092 | $25 |
| Pathology examination of tissue using a microscope, moderately low complexity | 48 | $562 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 88 | $381 | $4 |
| Blood smear interpretation by physician with written report | 13 | $298 | $23 |
2020: 19 services
| Pathology examination of tissue using a microscope, intermediate complexity | 483 | $34,068 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 173 | $29,031 | $28 |
| Special stained specimen slides to examine tissue, initial procedure | 238 | $10,542 | $35 |
| Pathology examination of tissue using a microscope, moderately high complexity | 85 | $9,770 | $82 |
| Microscopic genetic analysis of tumor, manual | 120 | $9,366 | $41 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 92 | $8,214 | $81 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 64 | $5,408 | $38 |
| Bone marrow, smear interpretation | 85 | $4,207 | $47 |
| Genetic sequencing localization, initial procedure | 86 | $4,050 | $43 |
| Pathology examination of tissue using a microscope, high complexity | 19 | $2,757 | $145 |
| Genetic sequencing localization, each additional procedure | 70 | $2,722 | $34 |
| Special stained specimen slides to examine tissue including interpretation and report | 97 | $1,826 | $12 |
| Preparation of tissue for examination by removing any calcium present | 106 | $1,388 | $12 |
| Pathology examination of specimen during surgery, first tissue block | 14 | $1,054 | $62 |
| Special stained specimen slides to identify organisms including interpretation and report | 21 | $942 | $26 |
| Blood smear interpretation by physician with written report | 17 | $399 | $23 |
| Pathology examination of tissue using a microscope, moderately low complexity | 30 | $355 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 66 | $295 | $4 |
| Examination of archival tissue for genetic analysis | 12 | $211 | $18 |
2019: 21 services
| Pathology examination of tissue using a microscope, intermediate complexity | 683 | $50,539 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 224 | $30,991 | $27 |
| Special stained specimen slides to examine tissue, initial procedure | 330 | $13,887 | $34 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 123 | $11,121 | $80 |
| Microscopic genetic analysis of tumor, manual | 148 | $10,637 | $41 |
| Pathology examination of tissue using a microscope, moderately high complexity | 80 | $8,765 | $80 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 88 | $7,085 | $37 |
| Bone marrow, smear interpretation | 113 | $5,642 | $47 |
| Genetic sequencing localization, initial procedure | 117 | $5,217 | $42 |
| Pathology examination of tissue using a microscope, high complexity | 26 | $3,983 | $142 |
| Genetic sequencing localization, each additional procedure | 108 | $3,902 | $33 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 14 | $2,386 | $170 |
| Pathology examination of specimen during surgery, first tissue block | 21 | $1,946 | $61 |
| Preparation of tissue for examination by removing any calcium present | 151 | $1,936 | $12 |
| Special stained specimen slides to examine tissue including interpretation and report | 123 | $1,782 | $11 |
| Special stained specimen slides to identify organisms including interpretation and report | 36 | $1,353 | $26 |
| Pathology examination of tissue using a microscope, moderately low complexity | 58 | $685 | $11 |
| Blood smear interpretation by physician with written report | 25 | $604 | $23 |
| Pathology examination of tissue using a microscope, limited examination | 104 | $453 | $4 |
| Examination of archival tissue for genetic analysis | 13 | $244 | $19 |
| Pathology examination of tissue using a microscope | 16 | $91 | $6 |
2018: 19 services
| Pathology examination of tissue using a microscope, intermediate complexity | 611 | $42,252 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 168 | $25,210 | $27 |
| Special stained specimen slides to examine tissue, initial procedure | 242 | $9,579 | $34 |
| Microscopic genetic analysis of tumor, manual | 109 | $9,337 | $43 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 94 | $7,999 | $79 |
| Pathology examination of tissue using a microscope, moderately high complexity | 66 | $7,679 | $80 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 57 | $4,938 | $37 |
| Genetic sequencing localization, initial procedure | 90 | $4,454 | $42 |
| Bone marrow, smear interpretation | 79 | $3,733 | $46 |
| Genetic sequencing localization, each additional procedure | 73 | $2,745 | $33 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 14 | $2,288 | $163 |
| Pathology examination of tissue using a microscope, high complexity | 14 | $1,990 | $142 |
| Special stained specimen slides to identify organisms including interpretation and report | 49 | $1,651 | $25 |
| Preparation of tissue for examination by removing any calcium present | 105 | $1,420 | $12 |
| Special stained specimen slides to examine tissue including interpretation and report | 88 | $1,363 | $11 |
| Pathology examination of specimen during surgery, first tissue block | 12 | $1,033 | $61 |
| Pathology examination of tissue using a microscope, moderately low complexity | 44 | $541 | $11 |
| Blood smear interpretation by physician with written report | 14 | $324 | $23 |
| Pathology examination of tissue using a microscope, limited examination | 72 | $303 | $4 |
2017: 19 services
| Pathology examination of tissue using a microscope, intermediate complexity | 617 | $41,735 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 160 | $21,689 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 100 | $13,235 | $80 |
| Microscopic genetic analysis of tumor, manual | 108 | $11,718 | $52 |
| Special stained specimen slides to examine tissue, initial procedure | 236 | $9,949 | $33 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 70 | $4,707 | $37 |
| Pathology examination of tissue using a microscope, high complexity | 28 | $4,539 | $142 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 50 | $4,330 | $82 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 15 | $2,525 | $168 |
| Bone marrow, smear interpretation | 52 | $2,485 | $45 |
| Genetic sequencing localization, initial procedure | 52 | $2,433 | $42 |
| Pathology examination of specimen during surgery, first tissue block | 22 | $2,350 | $60 |
| Genetic sequencing localization, each additional procedure | 48 | $1,817 | $33 |
| Special stained specimen slides to identify organisms including interpretation and report | 39 | $1,493 | $26 |
| Preparation of tissue for examination by removing any calcium present | 95 | $1,273 | $12 |
| Special stained specimen slides to examine tissue including interpretation and report | 71 | $1,035 | $11 |
| Pathology examination of tissue using a microscope, moderately low complexity | 56 | $667 | $11 |
| Pathology examination of specimen during surgery | 14 | $479 | $34 |
| Pathology examination of tissue using a microscope, limited examination | 79 | $330 | $4 |
2016: 20 services
| Pathology examination of tissue using a microscope, intermediate complexity | 516 | $35,585 | $36 |
| Special stained specimen slides to examine tissue, each additional procedure | 119 | $15,988 | $25 |
| Pathology examination of tissue using a microscope, moderately high complexity | 88 | $10,355 | $80 |
| Special stained specimen slides to examine tissue, initial procedure | 195 | $7,922 | $34 |
| Microscopic genetic analysis of tumor, manual | 44 | $5,173 | $51 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 48 | $4,106 | $37 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 23 | $3,425 | $143 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 28 | $2,850 | $102 |
| Pathology examination of tissue using a microscope, high complexity | 16 | $2,400 | $141 |
| Special stained specimen slides to identify organisms including interpretation and report | 32 | $1,438 | $26 |
| Genetic sequencing localization, initial procedure | 28 | $1,410 | $41 |
| Pathology examination of specimen during surgery, first tissue block | 16 | $1,315 | $60 |
| Evaluation of fine needle aspirate with interpretation and report | 14 | $1,280 | $67 |
| Bone marrow, smear interpretation | 26 | $1,184 | $46 |
| Cell examination of specimen, selective cellular enhancement technique | 30 | $999 | $26 |
| Preparation of tissue for examination by removing any calcium present | 51 | $671 | $12 |
| Special stained specimen slides to examine tissue including interpretation and report | 41 | $584 | $11 |
| Genetic sequencing localization, each additional procedure | 15 | $570 | $32 |
| Pathology examination of tissue using a microscope, limited examination | 102 | $513 | $4 |
| Pathology examination of tissue using a microscope, moderately low complexity | 44 | $477 | $11 |
2015: 22 services
| Pathology examination of tissue using a microscope, intermediate complexity | 556 | $36,933 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 115 | $11,293 | $20 |
| Pathology examination of tissue using a microscope, moderately high complexity | 54 | $9,203 | $79 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 41 | $7,226 | $168 |
| Special stained specimen slides to examine tissue, initial procedure | 171 | $6,584 | $33 |
| Microscopic genetic analysis of tumor, manual | 70 | $6,400 | $50 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 36 | $3,743 | $101 |
| Pathology examination of specimen during surgery, first tissue block | 34 | $3,079 | $59 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 52 | $2,962 | $36 |
| Pathology examination of tissue using a microscope, high complexity | 17 | $2,359 | $139 |
| Evaluation of fine needle aspirate with interpretation and report | 25 | $2,114 | $66 |
| Cell examination of specimen, selective cellular enhancement technique | 64 | $1,971 | $26 |
| Genetic sequencing localization, initial procedure | 26 | $1,747 | $41 |
| Bone marrow, smear interpretation | 34 | $1,521 | $45 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 12 | $896 | $41 |
| Special stained specimen slides to identify organisms including interpretation and report | 21 | $759 | $25 |
| Preparation of tissue for examination by removing any calcium present | 60 | $720 | $11 |
| Special stained specimen slides to examine tissue including interpretation and report | 41 | $686 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 98 | $462 | $4 |
| Evaluation of fine needle aspirate | 12 | $443 | $34 |
| Pathology examination of specimen during surgery, each additional tissue block | 11 | $436 | $29 |
| Pathology examination of tissue using a microscope, moderately low complexity | 27 | $291 | $10 |
2014: 21 services
| Pathology examination of tissue using a microscope, intermediate complexity | 604 | $40,583 | $34 |
| Pathology examination of tissue using a microscope, moderately high complexity | 71 | $10,720 | $76 |
| Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) | 116 | $6,845 | $11 |
| Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | 187 | $6,535 | $27 |
| Microscopic genetic analysis of tumor, manual | 47 | $4,277 | $48 |
| Evaluation of fine needle aspirate with interpretation and report | 31 | $2,910 | $65 |
| Pathology examination of tissue using a microscope, high complexity | 19 | $2,770 | $132 |
| Pathology examination of specimen during surgery, first tissue block | 31 | $2,511 | $57 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 22 | $2,439 | $98 |
| Microscopic genetic analysis of tissue, manual, initial procedure | 11 | $2,396 | $57 |
| Cell examination of specimen, selective cellular enhancement technique | 72 | $1,986 | $25 |
| Genetic sequencing localization, initial procedure | 14 | $1,292 | $54 |
| Bone marrow, smear interpretation | 21 | $915 | $44 |
| Evaluation of fine needle aspirate | 20 | $722 | $33 |
| Special stained specimen slides to identify organisms including interpretation and report | 18 | $621 | $25 |
| Pathology examination of specimen during surgery, each additional tissue block | 13 | $565 | $28 |
| Preparation of tissue for examination by removing any calcium present | 43 | $515 | $11 |
| Special stained specimen slides to examine tissue including interpretation and report | 33 | $509 | $11 |
| Pathology examination of specimen during surgery | 13 | $424 | $33 |
| Pathology examination of tissue using a microscope, limited examination | 85 | $379 | $4 |
| Pathology examination of tissue using a microscope, moderately low complexity | 34 | $357 | $10 |
2013: 14 services
| Pathology examination of tissue using a microscope, intermediate complexity | 577 | $40,044 | $33 |
| Special stained specimen slides to examine tissue, initial procedure | 142 | $19,647 | $38 |
| Pathology examination of tissue using a microscope, moderately high complexity | 54 | $8,201 | $74 |
| Pathology examination of tissue using a microscope, high complexity | 23 | $3,426 | $132 |
| Cell examination of specimen, selective cellular enhancement technique | 56 | $3,238 | $52 |
| Microscopic genetic analysis of tumor, manual | 25 | $2,760 | $47 |
| Evaluation of fine needle aspirate with interpretation and report | 30 | $2,460 | $63 |
| Pathology examination of specimen during surgery, first tissue block | 24 | $1,346 | $56 |
| Special stained specimen slides to identify organisms including interpretation and report | 34 | $1,223 | $24 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 11 | $1,031 | $94 |
| Pathology examination of tissue using a microscope, moderately low complexity | 37 | $434 | $10 |
| Preparation of tissue for examination by removing any calcium present | 30 | $385 | $11 |
| Special stained specimen slides to examine tissue including interpretation and report | 24 | $352 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 76 | $299 | $4 |
Medicaid work
$2,236 in 2024
Medicaid paid $2,236 for 73 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 61 | $1,815 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 12 | $421 |
| 2024 | 73 | 2 | 17 | $2,236 |
| 2023 | 36 | 1 | 18 | $229 |
| 2021 | 33 | 2 | 18 | $456 |
| 2019 | 52 | 1 | 14 | $1,271 |
| 2018 | 24 | 1 | 12 | $443 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 36 | $229 |
2021
| TISSUE EXAM BY PATHOLOGIST | 19 | $259 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 14 | $197 |
2019
| TISSUE EXAM BY PATHOLOGIST | 52 | $1,271 |
2018
| TISSUE EXAM BY PATHOLOGIST | 24 | $443 |
Money from drug and device companies
$161 in 2019
A payment is not proof that care is biased.
| Stemline Therapeutics | Elzonris | $67 | 1 payment
|
| Seattle Genetics | None | $33 | 1 payment
|
| Amgen | Nplate | $29 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $20 | 1 payment
|
| Foundation Medicine | Foundationone | $13 | 1 payment
|
See all 5 published payments
| Seattle Genetics | Meals · 2019-09-13 | None | $33 |
| Stemline Therapeutics | Meals · 2019-09-12 | Elzonris | $67 |
| Foundation Medicine | Meals · 2019-08-05 | Foundationone | $13 |
| Amgen | Meals · 2019-02-25 | Nplate | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2019-02-21 | Tagrisso | $20 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 90.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1629268453
- Licence
- CA A120856California A120856: Current · expires 2027-07-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- MN ENROLLED
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X)
- Mailing address
- 5700 Southwyck Blvd, Toledo, OH, 43614
- NPI first listed
- 2007-07-27
- NPI last updated
- 2015-04-22
This is when the NPI record was last certified, not a medical board exam.